To Screen or Not to Screen? Study Weighs Benefits of Population-Wide BRCA Testing

Population-wide screening of Ashkenazi Jews for BRCA1/BRCA2 mutations may help identify women at high risk who would not have been identified by screening based only on family or personal history of cancer, a new study suggests.